Understanding Heart Surgery Risk: STS Score, EuroSCORE II, and What They Mean for You.

Every cardiac surgical procedure carries risk — from the extremely low (under 1% for routine CABG or aortic valve replacement at experienced centers) to the substantial (10-15% for complex reoperative or combined procedures in frail patients). Understanding your individual risk is essential for informed decision-making and is a cornerstone of the shared decision-making model emphasized by the ACC/AHA and ESC guidelines.

Risk assessment serves multiple purposes: it helps surgeons and cardiologists determine whether surgery is appropriate, guides the choice between surgical and less invasive alternatives (such as TAVR vs SAVR for aortic stenosis), allows meaningful comparison of outcomes across institutions and surgeons, and helps patients and families set realistic expectations about the procedure.

The Heart Team approach — a Class I recommendation in the ACC/AHA Guidelines for Valvular Heart Disease — relies on objective risk assessment to frame the discussion between cardiologists and surgeons. When a cardiologist says "this patient is high-risk for surgery," what do they mean? Risk scores provide the quantitative framework for that conversation.

At WhiteGloveMD, risk assessment using the STS score, EuroSCORE II, and our proprietary WGMD Composite Risk Score is a core component of every clinical evaluation.

The Society of Thoracic Surgeons Predicted Risk of Mortality (STS-PROM) is the most widely used risk calculator in cardiac surgery, developed from a database of over 7 million cardiac surgical procedures performed in North America. It is the benchmark against which individual surgeons and institutions measure their outcomes.

The STS calculator predicts risk for specific procedures: isolated CABG, isolated aortic valve replacement, isolated mitral valve surgery, and combined procedures (CABG + valve). It incorporates approximately 40 preoperative variables including:

• Demographics: Age, sex, race, height, weight, body surface area
• Cardiac function: Ejection fraction, heart failure class, cardiogenic shock, arrhythmias
• Comorbidities: Diabetes (and insulin dependence), renal function (creatinine/dialysis), COPD, cerebrovascular disease, peripheral vascular disease
• Acuity: Elective, urgent, emergent, or salvage
• Prior interventions: Previous cardiac surgery, PCI, IABP
• Procedure-specific: Number of diseased vessels, left main disease, valve pathology

The STS score outputs predicted risks for: operative mortality, stroke, prolonged ventilation (>24 hours), deep sternal wound infection, reoperation, renal failure, morbidity/mortality composite, and length of stay >14 days.

Risk categories are generally interpreted as: low risk (STS-PROM <3%), intermediate risk (3-8%), high risk (>8%), and extreme risk (>15% or specific frailty/anatomic factors). These thresholds are particularly important for the TAVR vs SAVR decision, where ACC/AHA guidelines use STS-PROM to guide treatment strategy.

The European System for Cardiac Operative Risk Evaluation (EuroSCORE II) is an updated version of the original EuroSCORE, recalibrated in 2012 using contemporary data from 22,381 patients across 43 countries. It provides a single predicted operative mortality estimate for all cardiac surgical procedures.

EuroSCORE II includes 18 variables grouped into patient-related, cardiac-related, and operation-related factors:

• Patient factors: Age, sex, renal function (creatinine clearance), extracardiac arteriopathy, poor mobility, previous cardiac surgery, chronic lung disease, active endocarditis, critical preoperative state, diabetes on insulin
• Cardiac factors: NYHA class, CCS angina class, LV function (EF), recent MI, pulmonary hypertension
• Operative factors: Urgency, weight of the intervention, surgery on thoracic aorta

Compared to the STS score, EuroSCORE II is simpler (fewer variables), applicable to a broader range of cardiac procedures (including aortic surgery, which is not covered by STS procedure-specific models), and used more widely outside North America. However, multiple validation studies have shown that EuroSCORE II tends to overestimate risk in low-risk patients and underestimate risk in high-risk patients — a calibration concern that limits its accuracy at the extremes.

The original EuroSCORE (logistic version) significantly overestimated risk and should no longer be used. When you see "EuroSCORE" in clinical literature, verify whether it refers to the original logistic EuroSCORE or the updated EuroSCORE II, as the differences are substantial.

While the STS score and EuroSCORE II are the most widely used, several other risk assessment tools provide complementary information:

• AATS Risk Calculator: Developed by the American Association for Thoracic Surgery, this model incorporates over 75 variables to predict operative mortality, morbidity, prolonged ventilation, wound infection, stroke, reoperation, and renal failure. It provides granular predictions for complex combined procedures and is used by WhiteGloveMD as part of our comprehensive risk evaluation.
• SYNTAX Score: Not a surgical risk score per se, but an anatomic complexity score for coronary artery disease that guides the CABG vs PCI decision. Higher SYNTAX scores (>32) favor CABG, while lower scores (<22) suggest PCI may be equivalent.
• Frailty Assessment: Increasingly recognized as a critical predictor not captured by traditional risk scores. The 5-meter walk test, grip strength, serum albumin, Katz Index of Independence, and the Essential Frailty Toolset (EFT) are used to identify patients whose frailty places them at disproportionately higher risk than mathematical models predict.
• WGMD Composite Risk Score: WhiteGloveMD's proprietary scoring system integrates STS-PROM, EuroSCORE II, AATS predictions, frailty metrics, and anatomic complexity into a unified risk profile. This composite approach addresses the limitations of any single model and provides patients and providers with the most comprehensive risk picture available.

No risk score is perfectly accurate. They are statistical models that predict population-level outcomes, not individual-level certainties. A patient with a 5% predicted mortality has a 95% chance of survival — but also a 1-in-20 chance of not surviving. Understanding this distinction is essential for informed consent.

Risk scores are not just academic exercises — they directly influence clinical decisions at critical junctures:

TAVR vs SAVR for aortic stenosis: The 2020 ACC/AHA Guidelines use STS-PROM as a key factor in determining the optimal approach. For patients with STS-PROM >8%, TAVR is generally preferred (Class I). For STS-PROM <3%, surgical AVR is generally preferred for patients under 65 (Class I). For intermediate risk (STS-PROM 3-8%), shared decision-making guides the choice based on anatomy, valve durability considerations, and patient preferences. Learn more about this decision in our TAVR vs SAVR comparison.

Medical therapy vs surgery for coronary disease: The ISCHEMIA trial demonstrated that in patients with stable ischemic heart disease, an initial invasive strategy (PCI or CABG) did not reduce major cardiovascular events compared to optimal medical therapy. Risk scores help identify which patients might benefit most from revascularization despite this finding.

Timing of valve surgery: The decision between watchful waiting and early surgery for asymptomatic valve disease depends on the balance between the risk of the procedure (quantified by risk scores) and the risk of disease progression (guided by clinical parameters).

Surgical approach: Risk scores influence the choice between conventional and minimally invasive approaches. Higher-risk patients may benefit from less invasive techniques, while lower-risk patients can tolerate the potentially superior exposure of conventional surgery.

Risk scores are powerful tools, but patients and physicians must understand their limitations:

• Population-level predictions, not individual guarantees: A 2% predicted mortality means that out of 100 similar patients, 2 are expected to die. It does not mean any individual patient has exactly a 2% chance. Your actual risk depends on factors beyond what any model captures.
• Missing variables: Neither STS nor EuroSCORE II captures frailty, cognitive function, psychological resilience, social support, nutritional status, or "eyeball" clinical assessment — all of which experienced surgeons factor into their judgment. A malnourished, isolated 80-year-old with an STS-PROM of 3% may actually be much higher risk than the number suggests.
• Institutional variation: Risk scores predict average outcomes across all centers. A high-volume center with fellowship-trained surgeons may achieve mortality rates well below STS predictions, while a low-volume center may exceed them. The surgeon and institution matter enormously.
• Calibration drift: Risk models are trained on historical data. As surgical techniques, anesthesia, and perioperative care improve, scores may overestimate contemporary risk. The STS model is periodically recalibrated, but some lag is inevitable.
• Missing outcomes: Risk scores primarily predict mortality and major morbidity. They do not predict quality of life, functional recovery, chronic pain, psychological impact, or patient satisfaction — outcomes that may be more important to patients than survival statistics.

This is precisely why a Human Team evaluation — not just a risk calculator — is essential. Experienced cardiac surgeons integrate quantitative risk scores with qualitative clinical judgment to provide patients with a realistic, personalized assessment of their operative risk.

When meeting with a cardiac surgeon about a proposed procedure, these questions can help you understand your personal risk profile:

• "What is my STS predicted risk of mortality?" Every cardiac surgical program calculates this. If your surgeon cannot provide it, that is a concern.
• "How does your personal mortality rate compare to the STS predicted risk?" This reveals whether the surgeon's outcomes are better, equal to, or worse than national benchmarks. Fellowship-trained surgeons at high-volume centers typically achieve observed-to-expected mortality ratios below 1.0.
• "What is the STS star rating for your program?" STS rates programs as 1-star (below average), 2-star (average), or 3-star (above average) for specific procedures. A 3-star rating means the program's outcomes are statistically better than the national average.
• "Are there risk factors in my case that the score might not capture?" This opens a conversation about frailty, complexity, and clinical nuance.
• "If my risk is elevated, are there ways to reduce it before surgery?" Prehabilitation (exercise, nutrition optimization, smoking cessation, anemia correction) can meaningfully reduce operative risk in elective cases. The Enhanced Recovery After Surgery (ERAS) protocols have demonstrated improved outcomes.
• "What is the risk of NOT having surgery?" Sometimes the risk of the natural history of the disease exceeds the surgical risk. This comparison is essential for informed decision-making.

WhiteGloveMD provides comprehensive risk assessment using STS, EuroSCORE II, AATS, and our proprietary WGMD Composite Score as part of every clinical evaluation. Request your review to receive a detailed, personalized risk analysis.